ID   COL11_HUMAN             Reviewed;         271 AA.
AC   Q9BWP8; A1IGE4; A1IGE5; A1IGE6; A7VJJ2; A7VJJ3; A7VJJ4; A7VJJ5; B2R9M5;
AC   B4E1G0; J3KQY9; Q5CZ85; Q7Z6N1;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 173.
DE   RecName: Full=Collectin-11;
DE   AltName: Full=Collectin kidney protein 1;
DE            Short=CL-K1;
DE   Flags: Precursor;
GN   Name=COLEC11; ORFNames=UNQ596/PRO1182;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7 AND 8), FUNCTION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=17179669; DOI=10.1111/j.1348-0421.2006.tb03868.x;
RA   Keshi H., Sakamoto T., Kawai T., Ohtani K., Katoh T., Jang S.-J.,
RA   Motomura W., Yoshizaki T., Fukuda M., Koyama S., Fukuzawa J., Fukuoh A.,
RA   Yoshida I., Suzuki Y., Wakamiya N.;
RT   "Identification and characterization of a novel human collectin CL-K1.";
RL   Microbiol. Immunol. 50:1001-1013(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 10), AND VARIANT
RP   ARG-219.
RC   TISSUE=Lung, and Ovary;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 9).
RC   TISSUE=Neuroblastoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 26-271 (ISOFORM 3).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   FUNCTION, DNA-BINDING, SUBUNIT, INTERACTION WITH MASP1, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=20956340; DOI=10.4049/jimmunol.1002185;
RA   Hansen S., Selman L., Palaniyar N., Ziegler K., Brandt J., Kliem A.,
RA   Jonasson M., Skjoedt M.O., Nielsen O., Hartshorn K., Joergensen T.J.,
RA   Skjoedt K., Holmskov U.;
RT   "Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with
RT   microbial-binding activity.";
RL   J. Immunol. 185:6096-6104(2010).
RN   [10]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=23954398; DOI=10.1016/j.molimm.2013.07.011;
RA   Henriksen M.L., Brandt J., Iyer S.S., Thielens N.M., Hansen S.;
RT   "Characterization of the interaction between collectin 11 (CL-11, CL-K1)
RT   and nucleic acids.";
RL   Mol. Immunol. 56:757-767(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12] {ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD}
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 116-270 OF HOMOTRIMER IN COMPLEX
RP   WITH CALCIUM AND CARBOHYDRATE, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   DISULFIDE BONDS, AND CHARACTERIZATION OF VARIANTS 3MC2 PRO-169; SER-204 AND
RP   SER-217 DEL.
RX   PubMed=25912189; DOI=10.1186/s12915-015-0136-2;
RA   Venkatraman Girija U., Furze C.M., Gingras A.R., Yoshizaki T., Ohtani K.,
RA   Marshall J.E., Wallis A.K., Schwaeble W.J., El-Mezgueldi M., Mitchell D.A.,
RA   Moody P.C., Wakamiya N., Wallis R.;
RT   "Molecular basis of sugar recognition by collectin-K1 and the effects of
RT   mutations associated with 3MC syndrome.";
RL   BMC Biol. 13:27-27(2015).
RN   [13]
RP   FUNCTION, AND VARIANTS 3MC2 PRO-169; SER-204 AND SER-217 DEL.
RX   PubMed=21258343; DOI=10.1038/ng.757;
RA   Rooryck C., Diaz-Font A., Osborn D.P., Chabchoub E.,
RA   Hernandez-Hernandez V., Shamseldin H., Kenny J., Waters A., Jenkins D.,
RA   Kaissi A.A., Leal G.F., Dallapiccola B., Carnevale F., Bitner-Glindzicz M.,
RA   Lees M., Hennekam R., Stanier P., Burns A.J., Peeters H., Alkuraya F.S.,
RA   Beales P.L.;
RT   "Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC
RT   syndrome.";
RL   Nat. Genet. 43:197-203(2011).
RN   [14]
RP   FUNCTION, AND VARIANT 3MC2 THR-166.
RX   PubMed=28301481; DOI=10.1371/journal.pgen.1006679;
RA   Munye M.M., Diaz-Font A., Ocaka L., Henriksen M.L., Lees M., Brady A.,
RA   Jenkins D., Morton J., Hansen S.W., Bacchelli C., Beales P.L.,
RA   Hernandez-Hernandez V.;
RT   "COLEC10 is mutated in 3MC patients and regulates early craniofacial
RT   development.";
RL   PLoS Genet. 13:E1006679-E1006679(2017).
CC   -!- FUNCTION: Lectin that plays a role in innate immunity, apoptosis and
CC       embryogenesis (PubMed:23954398, PubMed:25912189, PubMed:21258343).
CC       Calcium-dependent lectin that binds self and non-self glycoproteins
CC       presenting high mannose oligosaccharides with at least one terminal
CC       alpha-1,2-linked mannose epitope (PubMed:25912189). Primarily
CC       recognizes the terminal disaccharide of the glycan (PubMed:25912189).
CC       Also recognizes a subset of fucosylated glycans and lipopolysaccharides
CC       (PubMed:17179669, PubMed:25912189). Plays a role in innate immunity
CC       through its ability to bind non-self sugars presented by microorganisms
CC       and to activate the complement through the recruitment of MAPS1
CC       (PubMed:20956340, PubMed:25912189). Also plays a role in apoptosis
CC       through its ability to bind in a calcium-independent manner the DNA
CC       present at the surface of apoptotic cells and to activate the
CC       complement in response to this binding (Probable). Finally, plays a
CC       role in development, probably serving as a guidance cue during the
CC       migration of neural crest cells and other cell types during
CC       embryogenesis (PubMed:21258343, PubMed:28301481).
CC       {ECO:0000269|PubMed:17179669, ECO:0000269|PubMed:20956340,
CC       ECO:0000269|PubMed:21258343, ECO:0000269|PubMed:23954398,
CC       ECO:0000269|PubMed:25912189, ECO:0000269|PubMed:28301481,
CC       ECO:0000305|PubMed:20956340, ECO:0000305|PubMed:23954398}.
CC   -!- SUBUNIT: Homotrimer; disulfide-linked (PubMed:20956340,
CC       PubMed:25912189). Interacts with MASP1; probably triggers the lectin
CC       pathway of complement (PubMed:20956340). {ECO:0000269|PubMed:20956340,
CC       ECO:0000269|PubMed:25912189}.
CC   -!- INTERACTION:
CC       Q9BWP8; Q9BWP8: COLEC11; NbExp=4; IntAct=EBI-25809731, EBI-25809731;
CC       Q9BWP8-1; Q9BXI9-2: C1QTNF6; NbExp=3; IntAct=EBI-27104870, EBI-27104631;
CC       PRO_0000315044; P07911: UMOD; NbExp=2; IntAct=EBI-26568155, EBI-2819647;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:25912189}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC       Name=1; Synonyms=CL-K1-I;
CC         IsoId=Q9BWP8-1; Sequence=Displayed;
CC       Name=2; Synonyms=CL-K1-Ia;
CC         IsoId=Q9BWP8-2; Sequence=VSP_030468;
CC       Name=3; Synonyms=CL-K1-Ib;
CC         IsoId=Q9BWP8-3; Sequence=VSP_030470;
CC       Name=4; Synonyms=CL-K1-II;
CC         IsoId=Q9BWP8-4; Sequence=VSP_030466;
CC       Name=5; Synonyms=CL-K1-Ic;
CC         IsoId=Q9BWP8-5; Sequence=VSP_030467;
CC       Name=6; Synonyms=CL-K1-IIa;
CC         IsoId=Q9BWP8-6; Sequence=VSP_030465, VSP_030469;
CC       Name=7; Synonyms=CL-K1-IIb;
CC         IsoId=Q9BWP8-7; Sequence=VSP_030466, VSP_030470;
CC       Name=8; Synonyms=CL-K1-IIc;
CC         IsoId=Q9BWP8-8; Sequence=VSP_030463, VSP_030471;
CC       Name=9;
CC         IsoId=Q9BWP8-9; Sequence=VSP_030464;
CC       Name=10;
CC         IsoId=Q9BWP8-10; Sequence=VSP_045532;
CC   -!- TISSUE SPECIFICITY: Ubiquitous (PubMed:17179669). Detected in adrenal
CC       gland, kidney, liver, ovaries and testis (at protein level)
CC       (PubMed:20956340). {ECO:0000269|PubMed:17179669,
CC       ECO:0000269|PubMed:20956340}.
CC   -!- DISEASE: 3MC syndrome 2 (3MC2) [MIM:265050]: A form of 3MC syndrome, an
CC       autosomal recessive disorder characterized by facial dysmorphism,
CC       craniosynostosis, learning disability, and genital, limb and
CC       vesicorenal anomalies. Facial features include hypertelorism,
CC       blepharophimosis, blepharoptosis and highly arched eyebrows, cleft lip
CC       and/or palate. The term 3MC syndrome includes Carnevale, Mingarelli,
CC       Malpuech, and Michels syndromes. {ECO:0000269|PubMed:21258343,
CC       ECO:0000269|PubMed:25912189, ECO:0000269|PubMed:28301481}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the COLEC10/COLEC11 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Collectin K1;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_225";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB119525; BAF43301.1; -; mRNA.
DR   EMBL; AB119650; BAF43302.1; -; mRNA.
DR   EMBL; AB119651; BAF43303.1; -; mRNA.
DR   EMBL; AB119652; BAF43304.1; -; mRNA.
DR   EMBL; AB119684; BAF79604.1; -; mRNA.
DR   EMBL; AB119685; BAF79605.1; -; mRNA.
DR   EMBL; AB119686; BAF79606.1; -; mRNA.
DR   EMBL; AB119687; BAF79607.1; -; mRNA.
DR   EMBL; AY358439; AAQ88805.1; -; mRNA.
DR   EMBL; AK303824; BAG64772.1; -; mRNA.
DR   EMBL; AK313840; BAG36572.1; -; mRNA.
DR   EMBL; AC010907; AAY24235.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX01053.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX01054.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX01055.1; -; Genomic_DNA.
DR   EMBL; BC000078; AAH00078.1; -; mRNA.
DR   EMBL; BC009951; AAH09951.1; -; mRNA.
DR   EMBL; CR936641; CAI56781.1; -; mRNA.
DR   CCDS; CCDS1649.1; -. [Q9BWP8-1]
DR   CCDS; CCDS1650.1; -. [Q9BWP8-9]
DR   CCDS; CCDS58689.1; -. [Q9BWP8-10]
DR   CCDS; CCDS58690.1; -. [Q9BWP8-3]
DR   CCDS; CCDS58691.1; -. [Q9BWP8-4]
DR   CCDS; CCDS58692.1; -. [Q9BWP8-7]
DR   CCDS; CCDS58693.1; -. [Q9BWP8-6]
DR   CCDS; CCDS58694.1; -. [Q9BWP8-8]
DR   RefSeq; NP_001242911.1; NM_001255982.1. [Q9BWP8-2]
DR   RefSeq; NP_001242912.1; NM_001255983.1. [Q9BWP8-3]
DR   RefSeq; NP_001242913.1; NM_001255984.1. [Q9BWP8-5]
DR   RefSeq; NP_001242914.1; NM_001255985.1. [Q9BWP8-10]
DR   RefSeq; NP_001242915.1; NM_001255986.1. [Q9BWP8-4]
DR   RefSeq; NP_001242916.1; NM_001255987.1. [Q9BWP8-6]
DR   RefSeq; NP_001242917.1; NM_001255988.1. [Q9BWP8-7]
DR   RefSeq; NP_001242918.1; NM_001255989.1. [Q9BWP8-8]
DR   RefSeq; NP_076932.1; NM_024027.4. [Q9BWP8-1]
DR   RefSeq; NP_954705.1; NM_199235.2. [Q9BWP8-9]
DR   PDB; 4YLI; X-ray; 2.45 A; A/B/C/D/E/F=116-270.
DR   PDB; 4YMD; X-ray; 2.87 A; A/B/C/D/E/F=116-270.
DR   PDBsum; 4YLI; -.
DR   PDBsum; 4YMD; -.
DR   AlphaFoldDB; Q9BWP8; -.
DR   SMR; Q9BWP8; -.
DR   BioGRID; 122460; 23.
DR   ComplexPortal; CPX-6181; CL-LK-MASP1 lectin-protease complex.
DR   ComplexPortal; CPX-6240; CL-LK-MASP2 lectin-protease complex.
DR   IntAct; Q9BWP8; 14.
DR   STRING; 9606.ENSP00000411770; -.
DR   UniLectin; Q9BWP8; -.
DR   iPTMnet; Q9BWP8; -.
DR   PhosphoSitePlus; Q9BWP8; -.
DR   BioMuta; COLEC11; -.
DR   DMDM; 74733453; -.
DR   MassIVE; Q9BWP8; -.
DR   PaxDb; Q9BWP8; -.
DR   PeptideAtlas; Q9BWP8; -.
DR   PRIDE; Q9BWP8; -.
DR   ProteomicsDB; 79295; -. [Q9BWP8-1]
DR   ProteomicsDB; 79296; -. [Q9BWP8-2]
DR   ProteomicsDB; 79297; -. [Q9BWP8-3]
DR   ProteomicsDB; 79298; -. [Q9BWP8-4]
DR   ProteomicsDB; 79299; -. [Q9BWP8-5]
DR   ProteomicsDB; 79300; -. [Q9BWP8-6]
DR   ProteomicsDB; 79301; -. [Q9BWP8-7]
DR   ProteomicsDB; 79302; -. [Q9BWP8-8]
DR   ProteomicsDB; 79303; -. [Q9BWP8-9]
DR   Antibodypedia; 26364; 198 antibodies from 28 providers.
DR   DNASU; 78989; -.
DR   Ensembl; ENST00000236693.11; ENSP00000236693.7; ENSG00000118004.18. [Q9BWP8-9]
DR   Ensembl; ENST00000349077.9; ENSP00000339168.4; ENSG00000118004.18. [Q9BWP8-1]
DR   Ensembl; ENST00000382062.6; ENSP00000371494.2; ENSG00000118004.18. [Q9BWP8-3]
DR   Ensembl; ENST00000402794.4; ENSP00000384882.1; ENSG00000118004.18. [Q9BWP8-6]
DR   Ensembl; ENST00000402922.2; ENSP00000385653.1; ENSG00000118004.18. [Q9BWP8-7]
DR   Ensembl; ENST00000403096.7; ENSP00000385130.3; ENSG00000118004.18. [Q9BWP8-4]
DR   Ensembl; ENST00000404205.5; ENSP00000385827.1; ENSG00000118004.18. [Q9BWP8-8]
DR   Ensembl; ENST00000418971.6; ENSP00000411770.2; ENSG00000118004.18. [Q9BWP8-10]
DR   GeneID; 78989; -.
DR   KEGG; hsa:78989; -.
DR   MANE-Select; ENST00000349077.9; ENSP00000339168.4; NM_024027.5; NP_076932.1.
DR   UCSC; uc002qxz.5; human. [Q9BWP8-1]
DR   CTD; 78989; -.
DR   DisGeNET; 78989; -.
DR   GeneCards; COLEC11; -.
DR   HGNC; HGNC:17213; COLEC11.
DR   HPA; ENSG00000118004; Tissue enhanced (gallbladder, liver).
DR   MalaCards; COLEC11; -.
DR   MIM; 265050; phenotype.
DR   MIM; 612502; gene.
DR   neXtProt; NX_Q9BWP8; -.
DR   OpenTargets; ENSG00000118004; -.
DR   Orphanet; 293843; 3MC syndrome.
DR   PharmGKB; PA26737; -.
DR   VEuPathDB; HostDB:ENSG00000118004; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000159468; -.
DR   HOGENOM; CLU_049894_3_2_1; -.
DR   InParanoid; Q9BWP8; -.
DR   OMA; HITMYFL; -.
DR   OrthoDB; 1105722at2759; -.
DR   PhylomeDB; Q9BWP8; -.
DR   TreeFam; TF330481; -.
DR   PathwayCommons; Q9BWP8; -.
DR   Reactome; R-HSA-166662; Lectin pathway of complement activation.
DR   Reactome; R-HSA-166663; Initial triggering of complement.
DR   Reactome; R-HSA-3000480; Scavenging by Class A Receptors.
DR   SignaLink; Q9BWP8; -.
DR   SIGNOR; Q9BWP8; -.
DR   BioGRID-ORCS; 78989; 15 hits in 1065 CRISPR screens.
DR   ChiTaRS; COLEC11; human.
DR   GenomeRNAi; 78989; -.
DR   Pharos; Q9BWP8; Tbio.
DR   PRO; PR:Q9BWP8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9BWP8; protein.
DR   Bgee; ENSG00000118004; Expressed in right lobe of liver and 108 other tissues.
DR   ExpressionAtlas; Q9BWP8; baseline and differential.
DR   Genevisible; Q9BWP8; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0009897; C:external side of plasma membrane; IC:ComplexPortal.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:1905370; C:serine-type endopeptidase complex; IC:ComplexPortal.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0120153; F:calcium-dependent carbohydrate binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0042806; F:fucose binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005537; F:mannose binding; IDA:UniProtKB.
DR   GO; GO:0070492; F:oligosaccharide binding; IDA:UniProtKB.
DR   GO; GO:0019730; P:antimicrobial humoral response; IDA:UniProtKB.
DR   GO; GO:0002752; P:cell surface pattern recognition receptor signaling pathway; IC:ComplexPortal.
DR   GO; GO:0006956; P:complement activation; IDA:UniProtKB.
DR   GO; GO:0001867; P:complement activation, lectin pathway; IDA:ComplexPortal.
DR   GO; GO:0032502; P:developmental process; ISS:UniProtKB.
DR   GO; GO:0097194; P:execution phase of apoptosis; IC:UniProtKB.
DR   GO; GO:1903028; P:positive regulation of opsonization; IDA:ComplexPortal.
DR   GO; GO:0006508; P:proteolysis; IDA:ComplexPortal.
DR   CDD; cd03591; CLECT_collectin_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR033990; Collectin_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF01391; Collagen; 2.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Coiled coil; Collagen;
KW   Developmental protein; Disease variant; Disulfide bond; Immunity;
KW   Innate immunity; Lectin; Mannose-binding; Metal-binding;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..271
FT                   /note="Collectin-11"
FT                   /id="PRO_0000315044"
FT   DOMAIN          65..112
FT                   /note="Collagen-like"
FT   DOMAIN          149..265
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          44..113
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          114..148
FT                   /evidence="ECO:0000255"
FT   BINDING         200
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YMD"
FT   BINDING         207
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         211
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         211
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         232
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         234
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         235
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         238
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI"
FT   BINDING         240
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YMD"
FT   BINDING         240
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         240
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         241
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         241
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         244
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YMD"
FT   BINDING         252..254
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YMD"
FT   BINDING         252
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   BINDING         253
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25912189,
FT                   ECO:0007744|PDB:4YLI, ECO:0007744|PDB:4YMD"
FT   DISULFID        170..264
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040,
FT                   ECO:0000269|PubMed:25912189, ECO:0007744|PDB:4YLI,
FT                   ECO:0007744|PDB:4YMD"
FT   DISULFID        242..256
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040,
FT                   ECO:0000269|PubMed:25912189, ECO:0007744|PDB:4YLI,
FT                   ECO:0007744|PDB:4YMD"
FT   VAR_SEQ         1..74
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:17179669"
FT                   /id="VSP_030463"
FT   VAR_SEQ         1..67
FT                   /note="MRGNLALVGVLISLAFLSLLPSGHPQPAGDDACSVQILVPGLKGDAGEKGDK
FT                   GAPGRPGRVGPTGEK -> MTPALCRSSSLASKGMRERRETKAPPDGLEESAPREKKQS
FT                   QPVVTASDISKRKCTSSFVEMGSQ (in isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_030464"
FT   VAR_SEQ         1..50
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:17179669"
FT                   /id="VSP_030465"
FT   VAR_SEQ         1..43
FT                   /note="MRGNLALVGVLISLAFLSLLPSGHPQPAGDDACSVQILVPGLK -> MWWVP
FT                   PSPYGCLPCALP (in isoform 4 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:17179669"
FT                   /id="VSP_030466"
FT   VAR_SEQ         1
FT                   /note="M -> MKKQRGVGVLPALRM (in isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045532"
FT   VAR_SEQ         43..90
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17179669"
FT                   /id="VSP_030467"
FT   VAR_SEQ         43..66
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17179669"
FT                   /id="VSP_030468"
FT   VAR_SEQ         51..67
FT                   /note="DKGAPGRPGRVGPTGEK -> MWWVPPSPYGCLPCALP (in isoform
FT                   6)"
FT                   /evidence="ECO:0000303|PubMed:17179669"
FT                   /id="VSP_030469"
FT   VAR_SEQ         67..90
FT                   /note="Missing (in isoform 3 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:17179669,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_030470"
FT   VAR_SEQ         75..91
FT                   /note="QKGSVGRHGKIGPIGSK -> MWWVPPSPYGCLPCALP (in isoform
FT                   8)"
FT                   /evidence="ECO:0000303|PubMed:17179669"
FT                   /id="VSP_030471"
FT   VARIANT         166
FT                   /note="A -> T (in 3MC2; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:28301481"
FT                   /id="VAR_078813"
FT   VARIANT         169
FT                   /note="S -> P (in 3MC2; no effect on homotrimerization;
FT                   loss of calcium-binding; loss of carbohydrate-binding
FT                   probably due to the inability to bind calcium; not secreted
FT                   probably due to degradation early after biosynthesis;
FT                   dbSNP:rs387907075)"
FT                   /evidence="ECO:0000269|PubMed:21258343,
FT                   ECO:0000269|PubMed:25912189"
FT                   /id="VAR_065901"
FT   VARIANT         204
FT                   /note="G -> S (in 3MC2; no effect on homotrimerization;
FT                   loss of calcium-binding; loss of carbohydrate-binding
FT                   probably due to the inability to bind calcium; not secreted
FT                   probably due to degradation early after biosynthesis;
FT                   dbSNP:rs387907076)"
FT                   /evidence="ECO:0000269|PubMed:21258343,
FT                   ECO:0000269|PubMed:25912189"
FT                   /id="VAR_065902"
FT   VARIANT         217
FT                   /note="Missing (in 3MC2; no effect on homotrimerization;
FT                   loss of calcium-binding; loss of carbohydrate-binding
FT                   probably due to the inability to bind calcium; not secreted
FT                   probably due to degradation early after biosynthesis)"
FT                   /evidence="ECO:0000269|PubMed:21258343,
FT                   ECO:0000269|PubMed:25912189"
FT                   /id="VAR_065903"
FT   VARIANT         219
FT                   /note="H -> R (in dbSNP:rs7567833)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_038143"
FT   CONFLICT        178
FT                   /note="S -> T (in Ref. 7; CAI56781)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        231
FT                   /note="G -> D (in Ref. 3; BAG64772)"
FT                   /evidence="ECO:0000305"
FT   HELIX           117..141
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   STRAND          150..161
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   HELIX           163..172
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   HELIX           183..195
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   STRAND          199..206
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   STRAND          208..210
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   HELIX           236..238
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   STRAND          242..246
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   STRAND          251..254
FT                   /evidence="ECO:0007829|PDB:4YLI"
FT   STRAND          260..267
FT                   /evidence="ECO:0007829|PDB:4YLI"
SQ   SEQUENCE   271 AA;  28665 MW;  A14A248CE41DB340 CRC64;
     MRGNLALVGV LISLAFLSLL PSGHPQPAGD DACSVQILVP GLKGDAGEKG DKGAPGRPGR
     VGPTGEKGDM GDKGQKGSVG RHGKIGPIGS KGEKGDSGDI GPPGPNGEPG LPCECSQLRK
     AIGEMDNQVS QLTSELKFIK NAVAGVRETE SKIYLLVKEE KRYADAQLSC QGRGGTLSMP
     KDEAANGLMA AYLAQAGLAR VFIGINDLEK EGAFVYSDHS PMRTFNKWRS GEPNNAYDEE
     DCVEMVASGG WNDVACHTTM YFMCEFDKEN M
//
